Search Dental Tribune

Remineralisation science and daily prevention: Study adds evidence on biomimetic enamel care

Attendees of the International Symposium on Dental Hygiene 2026 have the opportunity to learn more about remineralisation and Curasept Biosmalto at the company's booth. (Image: Curasept)
Curasept

Curasept

Thu. 9. July 2026

save

MILAN, Italy: As the International Symposium on Dental Hygiene brings renewed attention to prevention and progress in oral health, a recent in vitro study offers evidence on biomimetic remineralisation strategies used in the management of early enamel demineralisation. These products are intended to support mineral recovery in non-cavitated enamel lesions and to help protect enamel and dentine surfaces in patients at increased risk of mineral loss.

Hydroxyapatite and calcium phosphate-based technologies have gained attention because they aim to replicate or support the mineral processes naturally involved in enamel repair. However, not all remineralising technologies work in the same way. Differences in formulation, mineral availability, particle characteristics and interaction with the enamel surface can influence the remineralisation response.

Representative scanning electron micrographs of enamel surfaces showing sound enamel, demineralised enamel and enamel treated with casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), zinc hydroxyapatite (Zn-HA) or fluoridated amorphous calcium phosphate (F-ACP) at seven, 14, 21 and 28 days. (Image: © 2025 “Orilisi et al.”, licensed under “CC BY 4.0”)

Representative scanning electron micrographs of enamel surfaces showing sound enamel, demineralised enamel and enamel treated with casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), zinc hydroxyapatite (Zn-HA) or fluoridated amorphous calcium phosphate (F-ACP) at seven, 14, 21 and 28 days. (Image: © 2025 “Orilisi et al.”, licensed under “CC BY 4.0”)

A recent in vitro study compared three remineralising agents regarding their ability to support mineral recovery in artificially demineralised enamel lesions. Mineral recovery was assessed by calculating the calcium/phosphorus (Ca/P) ratio using energy-dispersive X-ray spectroscopy in conjunction with scanning electron microscopy (SEM), and surface morphology was evaluated using SEM. The study compared casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), zinc hydroxyapatite (Zn-HA) and fluoridated amorphous calcium phosphate (F-ACP), which is used in the Curasept Biosmalto professional mousse tested in the study.

The findings showed that all the tested formulations promoted a time-dependent remineralisation effect and that mineral recovery progressed over time. This confirmed that remineralisation is a gradual process requiring consistent application. However, differences between the formulations became evident during the evaluation period.

On the seventh day, the Zn-HA formulation demonstrated higher Ca/P values, suggesting an early mineral response. From the 14th day, however, the F-ACP formulation demonstrated significantly greater mineral gain compared with the other agents. By the 21st day, the F-ACP group showed Ca/P values approaching those of sound enamel. In comparison, CPP-ACP and Zn-HA demonstrated lower mineral recovery and reached a plateau earlier.

The SEM observations supported these findings. While CPP-ACP and Zn-HA showed partial surface recovery, the F-ACP group demonstrated a denser and more homogeneous enamel-like surface structure after 28 days, suggesting enhanced surface organisation following prolonged exposure.

From a clinical perspective, these findings reinforce two important principles for dental hygienists: the choice of remineralising technology matters, and remineralisation requires regular use over time. Remineralisation is not an immediate event; it is a biological process supported by consistent exposure and effective home care routines.

The study, titled “Time-effect comparative evaluation of three remineralizing agents on artificial enamel lesions: A SEM-EDX in vitro study”, was published online on 19 October 2025 in Journal of Clinical Medicine. More information about Curasept Biosmalto can be found at curasept.com. Curasept is a platinum sponsor of the 2026 International Symposium on Dental Hygiene.

Tags:
To post a reply please login or register
advertisement
advertisement